SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about voting results and scrutinizers report

16 Dec 2022 Evaluate

Bal Pharma has submitted the results of the remote e-voting for Extra Ordinary General Meeting of the Company held on 14.12.2022, along with the copy of scrutinizers report. The aforesaid reports are also available on its website: www.balpharma.com and also on the website of NSDL www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

77.30 -0.82 (-1.05%)
06-Jul-2026 14:36 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1908.95
Dr. Reddys Labs. 1367.60
Cipla 1464.20
Zydus Lifesciences 1150.00
Lupin 2487.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: